company score funding investors employees industries biz model city contact
Causaly

Biomedical research discovery tool.

64
$60M · Series B ICONIQ Growth, Index Ventures, Pentech Ventures 51 to 100 Health Tech, AI, Biotech, Pharma B2B, SaaS London, UK •••••••••••@causaly.com
Apollo Therapeutics

Portfolio of pharmaceutical research and discovery.

64
$33M · Series C Patient Square Capital, Rock Springs Capital, M&G Investments 1 to 10 Biotech, Pharma London, UK •••••••••••@apollotherapeutics.com
Pear Bio

Cancer treatment predictor software.

54
$14M · Series A Hoxton Ventures, Octopus Ventures, Fly Ventures 11 to 50 Health Tech, Biotech, Pharma B2B London, UK •••••••••••@pearbio.com
Flarin

Patent-protected anti-inflammatory painkiller.

54
$6M · Series A ITV AdVentures 1 to 10 Biotech, Pharma B2C London, UK •••••••••••@flarin.co.uk
ReViral

ReViral is a biotechnology company that develops and offers antiviral therapies for patients.

54
$44M · Series C Novo A/S, Andera Partners 11 to 50 Health Tech, Biotech, Pharma B2B London, UK •••••••••••@reviral.co.uk
Manual

Manual provides diagnostic tools and testing to help patients make health-related decisions.

50
$6M · Seed Felix Capital, Cherry Ventures, FJ Labs 11 to 50 Health Tech, Fashion, Pharma, Mobile, Ecommerce B2C London, UK •••••••••••@manual.co
Charac

The Charac app streamlines access to your local pharmacy. Skip the queue, save time and access all of your prescriptions from anywhere.

50
$1M · Seed NPA, MedAdvisor 1 to 10 Pharma, Mobile, Ecommerce B2C, Marketplace London, UK •••••••••••@charac.co.uk
Myricx Pharma

Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors.

50
$6M · Seed Sofinnova Partners 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B London, UK •••••••••••@myricxpharma.com
Lyphe group

Lyphe group is a reliable supplier of medical cannabis care and medicine.

50
$6M · Series A Leafy Tunnel 51 to 100 Health Tech, Agritech, Pharma, Manufacturing, Cannabis B2B London, UK •••••••••••@LYPHEGROUP.com
Epsilogen

Immuno-oncology company treats cancer with antibodies.

43
$2M · Series A AlbionVC, Epidarex Capital, Novartis Venture Fund 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics B2B London, UK •••••••••••@epsilogen.com
NK:IO

Immunotherapy for the treatment of cancer.

43
$1M · Seed Cancer Research Horizons, UK Innovation & Science Seed Fund 11 to 50 Biotech, Pharma B2C London, UK •••••••••••@nk-io.com
Peptone

We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.

43
$2M Hoxton Ventures, Bessemer Venture Partners 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B London, UK •••••••••••@peptone.io
Beckley Psytech

Short-duration psychedelic medicines developer for neuropsychiatric conditions.

42
$40M · Series B Leafy Tunnel, ATAI Life Sciences 1 to 10 Biotech, Pharma B2C Oxford, UK •••••••••••@beckleypsytech.com
Exogene

Exogene is a biotechnology company accelerating target & TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening.

39
$104k · Pre Seed Atomico, Entrepreneur First 1 to 10 Health Tech, AI, Biotech, Deep Tech, Pharma, Data and Analytics B2B London, UK •••••••••••@exogene.co.uk
Tuli Health

Tuli Health is a digital health platform that provides instant access to private medical appointments and testing.

39
$125k · Pre Seed Y Combinator 1 to 10 Health Tech, CPG & Consumer Goods, Pharma B2B, SaaS London, UK •••••••••••@tuli.health
Actimed Therapeutics

Developer of innovative treatment for muscle wasting disorders.

39
$1M · Seed Mankind Pharma 1 to 10 Biotech, Pharma London, UK •••••••••••@actimedtherapeutics.com
Healx

Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.

37
$56M · Series B Balderton Capital, Atomico, Amadeus Capital 51 to 100 Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@healx.io
Oxford Nanopore Technologies

Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins.

37
$275M Wellington Management 251 to 500 Health Tech, Biotech, Pharma, Robotics, Manufacturing, Genetics B2B Oxford, UK •••••••••••@nanoporetech.com
Osler Diagnostics

Lab-quality diagnostics for anyone, anywhere, at any time.

37
$85M Oxford Science Enterprises 51 to 100 Health Tech, Biotech, Deep Tech, Pharma B2B Oxford, UK •••••••••••@oslerdiagnostics.com
F2G

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.

37
$70M Sofinnova Partners, Novo A/S, Forbion Capital Partners 251 to 500 Health Tech, Biotech, Pharma, Genetics B2B Manchester, UK •••••••••••@f2g.com
Pheon Therapeutics

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

34
N/A Forbion Capital Partners 11 to 50 Health Tech, Biotech, Deep Tech, Pharma B2B London, UK •••••••••••@pheontx.com
MiNA Therapeutics

MiNA Therapeutics is a clinical-stage biotechnology company developing therapeutic medicines to harness gene activation mechanisms.

34
$29M 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Genetics B2B London, UK •••••••••••@minatx.com
Synthace

Synthace is a Life Sciences R&D cloud platform that enables experiments to be automated, with the resultant data seamlessly integrated.

34
N/A Sofinnova Partners 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Internet of Things B2B, SaaS London, UK •••••••••••@synthace.com
Pangaea Data

Pangaea Data provides a machine learning-based software solution making scientific and clinical data more meaningful.

34
N/A Ascension Ventures, Hambro Perks Ltd., IQ Capital Partners 1 to 10 Health Tech, AI, Machine Learning, Pharma, Data and Analytics, Business Intelligence B2B, SaaS London, UK •••••••••••@pangaeadata.ai
Veratrak

Supply chain platfrom for pharma.

31
$6M · Series A 11 to 50 Biotech, Pharma, Supply Chain & Logistics London, UK •••••••••••@veratrak.com
Nucleome Therapeutics

Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases

31
$43M Oxford Science Enterprises 1 to 10 Health Tech, Biotech, Pharma, Manufacturing, Genetics B2B Oxford, UK •••••••••••@nucleome.com
Re-Vana Therapeutics

Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company.

26
$11M Techstart Ventures 1 to 10 Health Tech, Pharma, Business Intelligence Belfast, UK •••••••••••@revanatx.com
Epitopea

Epitopea is a transatlantic cancer immunotherapeutics company.

26
$13M · Seed Cambridge Innovation Capital 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@epitopea.com
Theolytics

Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.

26
$6M · Series A Oxford Science Enterprises 11 to 50 Health Tech, Biotech, Pharma B2B Oxford, UK •••••••••••@theolytics.com
CV6 Therapeutics

CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel therapies.

26
$5M Techstart Ventures 1 to 10 Health Tech, Biotech, Pharma B2B Belfast, UK •••••••••••@cv6t.com
Abzena

Drug manufacturer.

26
$10M · Series A Biospring Partners 501 to 1000 Health Tech, Biotech, Pharma B2B, SaaS Cambridge, UK •••••••••••@abzena.com
PetMedix

PetMedix is a pet therapeutics startup.

26
$13M · Series A Cambridge Innovation Capital, Parkwalk Advisors 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@petmedix.co.uk
PillSorted

PillSorted is a Pharmacy, blending compassionate care and innovative technology to deliver a truly Personal Pharmacy service.

26
$6M · Seed Hoxton Ventures 11 to 50 Health Tech, CPG & Consumer Goods, Pharma, Ecommerce B2B, B2C, SaaS Cambridge, UK •••••••••••@pillsorted.com
Axol Bioscience

Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers.

26
$5M Calculus Capital 11 to 50 Health Tech, Biotech, Pharma, Business Intelligence B2B Cambridge, UK •••••••••••@axolbio.com
Pharmacierge

The free e-prescribing service chosen by Private GPs and Consultants to deliver medication to their patients nationwide

25
$1M · Seed 11 to 50 Health Tech, Pharma, Ecommerce B2B, B2C, Marketplace London, UK •••••••••••@pharmacierge.com
medino

Medino is the convenient online alternative to your High street Health and Wellness Shop.

25
$574k · Seed 1 to 10 Health Tech, CPG & Consumer Goods, Pharma, Fitness, Mobile, Ecommerce B2C London, UK •••••••••••@medino.com
CONNECT Care

On a mission to power the pharmacy of the future, giving people the confidence to make the most of their medicines.

25
$344k · Pre Seed 1 to 10 Health Tech, Hardware, Pharma, Mobile, Media and Entertainement, Ecommerce, ElderTech B2C London, UK •••••••••••@weconnect.care
Clerkenwell Health

A psychedelic-specialist clinical research organisation.

25
$970k · Pre Seed 1 to 10 Health Tech, Biotech, Pharma, Business Intelligence B2B, SaaS London, UK •••••••••••@clerkenwellhealth.com
Immunocore

Immunocore is a biotechnology company that specializes in the development of TCR bispecific immunotherapies.

23
$75M · Series C 251 to 500 Health Tech, Biotech, Pharma B2B Abingdon, UK •••••••••••@immunocore.com
Oxford Drug Design

Oxford Drug Design focuses on developing and delivering services and technologies in computer-aided drug discovery.

21
$2M ACF Investors 1 to 10 Health Tech, Biotech, Pharma, Food Delivery, Manufacturing B2B, SaaS Oxford, UK •••••••••••@oxforddrugdesign.com
Flarin

Patent-protected anti-inflammatory painkiller.

18
N/A 1 to 10 Biotech, Pharma London, UK •••••••••••@
Solvotrin Therapeutics

Solvotrin Therapeutics is a pharmaceutical company that focuses on improving and enhancing existing medications.

17
$7M 11 to 50 Health Tech, Biotech, Pharma B2B Cork, UK •••••••••••@solvotrin.com
NRG Therapeutics

NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.

17
$18M 1 to 10 Health Tech, Biotech, Pharma B2B Cambridge, UK •••••••••••@nrgtherapeutics.com
CardiaTec Biosciences

CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.

17
$1M · Pre Seed LinkedIn 1 to 10 Health Tech, AI, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@cardiatec.ai
Ochre Bio

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

17
$150k · Pre Seed Hoxton Ventures, Khosla Ventures, BACKED VC 11 to 50 Health Tech, Biotech, Pharma B2B Oxford, UK •••••••••••@ochre-bio.com
BrainWaveBank

BrainWaveBank makes it possible to measure and track brain activity and cognitive performance for anyone, anytime, anywhere.

17
$1M · Seed Techstart Ventures 11 to 50 Health Tech, Hardware, Biotech, Deep Tech, Pharma B2B, SaaS Belfast, UK •••••••••••@brainwavebank.com
Accession Therapeutics

Biopharma

17
$19M 11 to 50 Biotech, Pharma Oxford, UK •••••••••••@accessiontherapeutics.com
Monocl

Monocl empowers life science professionals with the complete global expert solution for impactful outreach and strategic engagement.

14
$3M 51 to 100 Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@monocl.com
PharmEnable

PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.

14
$2M · Seed 1 to 10 Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@pharmenable.com